Optima: Optimizing Prograf Therapy in Maintenance Allografts II
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
This study is designed to optimize calcineurin immunosuppressive regimens and evaluate
immunological and non-immunological markers that may explain mechanistic differences in these
agents and their effects.